Can tai chi ease chemo nerve damage? small study aims to find out
NCT ID NCT06807294
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 12-week virtual tai chi program is practical and acceptable for cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN), which causes pain, numbness, and balance problems. Researchers plan to enroll 21 participants who have completed chemotherapy and have ongoing nerve symptoms. The goal is to see if people can stick with the program and find it helpful, not yet to prove it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tai Chi program
What this could lead to
If successful, this could offer a gentle, accessible way to manage nerve pain and balance issues after chemotherapy.
What could go wrong
This is a very small feasibility study with only 21 participants, so results may not apply broadly. It tests whether the program is practical, not whether it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact